WHO approves use Sinopharm vaccine: PM

PRIME Minister Manasseh Sogavare has announced that the World Health Organisation [WHO] has approved the Sinopharm vaccine under its Emergency Use Listing.

The Prime Minister in his nationwide address today said Sinopharm is the fifth COVID-19 vaccine that has been approved by the WHO.

The other four are;

  • The Pfizer Vaccine
  • The Moderna Vaccine
  • The AstraZeneca Vaccine, and
  • The Johnson & Johnsons Vaccine.
See also  RSIPF acknowledges SIFF donation

“As you know, we already have 50,000 doses of the Sinopharm Vaccines in the country. With this approval from the WHO, the National Drugs, Medicines and Therapeutics Committee will now consider the approval of the Sinopharm vaccine for use in Solomon Islands during this week,” he said.

Prime Minister Sogavare said the MHMS Technical working group has met today to finalize the roll out plan of the Sinopharm Vaccines to be presented to the National Drugs, Medicines and Therapeutic committee for approval.

See also  Rehabilitation and reintegration of released prisoners requires a whole of society approach

“Fellow citizens, the approval by the WHO of the Sinopharm vaccine means that it has met the relevant efficacy and safety standards required from COVID-19 vaccines for administration to the people,” he said.

Prime Minister Sogavare said he will inform the nation in his next address on the roll-out plans for the Sinopharm vaccine.

See also  RSIPF acknowledges SIFF donation

– OPMC Press